NCT06729684 Development and Validation of a Personalized Digital Healthcare Model for Managing Side Effects in Breast Cancer Survivors
| NCT ID | NCT06729684 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Samsung Medical Center |
| Condition | Breast Cancer Survivorship |
| Study Type | INTERVENTIONAL |
| Enrollment | 72 participants |
| Start Date | 2024-11-13 |
| Primary Completion | 2025-05-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 72 participants in total. It began in 2024-11-13 with a primary completion date of 2025-05-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The ultimate goal of this research and development is to develop personalized digital healthcare technologies and self-management strategies based on self-assessment results and evidence, for breast cancer survivors who require management and recovery from acute and chronic side effects related to various treatments (surgery, chemotherapy, radiation, hormone therapy, etc.). Additionally, the aim is to verify the clinical applicability and establish a service model to address the diverse unmet healthcare needs of breast cancer survivors.
Eligibility Criteria
Inclusion Criteria: * Individuals who have undergone surgery for Stage 1-2 breast cancer * Individuals who have had a unilateral mastectomy * Aged 18 years or older and under 65 years * Possessing a smartphone with either an Android or iOS operating system * Individuals who voluntarily decide to participate after receiving detailed information about the study and provide written consent Exclusion Criteria: * Individuals who have undergone mastectomy only and are not receiving chemotherapy, radiation, or hormone therapy * Individuals with severe comorbidities (such as underlying diseases, neuromuscular disorders, cognitive or mental impairments, visual disabilities, etc.) that make it difficult to use the application or participate in the exercise intervention Discontinuation Criteria * Individuals who undergo delayed breast reconstruction surgery during the study period * Individuals who develop severe complications or experience cancer metastasis or recurrence in other organs during the study period, leading to a change in treatment * Occurrence of a major illness unrelated to study participation * Failure to comply with the instructions of the study physician * Situations where the participant voluntarily withdraws from the study or becomes unable to continue participating
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06729684 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Breast Cancer Survivorship. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06729684 currently recruiting?
Yes, NCT06729684 is actively recruiting participants. Contact the research team at k.sunwoo0418@gmail.com for enrollment information.
Where is the NCT06729684 trial being conducted?
This trial is being conducted at Seoul, South Korea.
Who is sponsoring the NCT06729684 clinical trial?
NCT06729684 is sponsored by Samsung Medical Center. The trial plans to enroll 72 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.